Articles

The top Republican challengers to Donald Trump went after him at their debate Wednesday night in Miami.

Tyson Foods is closing two of its smaller case ready meat facilities as it continues to cut costs.

Pharmaceutical company Takeda said Wednesday that the U.S. Food and Drug Administration approved Fruzaqla as a treatment for certain patients with colorectal cancer.

Goldman's chief economist, Jan Hatzius, thinks the negative effect of the Fed's rapid rate hikes on economic growth is already behind us.

Virgin Galactic narrowed its quarterly loss and more than doubled its revenue.

Managers of mutual funds focused on large-cap stocks in the U.S. did a stronger job of beating their benchmark last month, but they’re still struggling to do so year to date, according to BofA Global Research.

Wall Street is once again pushing the feel-good theory that there is a giant wave of money just waiting to come into the stock market and drive stock prices higher.

Arm shares were headed lower in Wednesday's late trading as the company's outlook missed the mark at the midpoint.

Grocery-delivery platform Instacart on Wednesday reported a nearly $2 billion loss in its first earnings report since going public, but its sales beat expectations and the company forecast "mid-single-digit" growth in the total value of transactions on its platform.

The app-monetization company blew past expectations with its latest quarterly results.

Russia has faced a wave of international sanctions following its 2022 invasion of Ukraine.

Almost nobody on Wall Street has the temerity to bet against the "Magnificent Seven" group of tech stocks.